- Home
- IMAX vs BLDEW Comparison
IMAX vs BLDEW Comparison
Compare IMAX & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAX
- BLDEW
- Stock Information
- Founded
- IMAX 1967
- BLDEW 2014
- Country
- IMAX Canada
- BLDEW United States
- Employees
- IMAX N/A
- BLDEW 322
- Industry
- IMAX
- BLDEW Transportation Services
- Sector
- IMAX
- BLDEW Consumer Discretionary
- Exchange
- IMAX Nasdaq
- BLDEW Nasdaq
- Market Cap
- IMAX N/A
- BLDEW N/A
- IPO Year
- IMAX 1994
- BLDEW N/A
- Fundamental
- Price
- IMAX $27.31
- BLDEW $0.22
- Analyst Decision
- IMAX Strong Buy
- BLDEW
- Analyst Count
- IMAX 11
- BLDEW 0
- Target Price
- IMAX $30.36
- BLDEW N/A
- AVG Volume (30 Days)
- IMAX 831.7K
- BLDEW 51.0K
- Earning Date
- IMAX 07-24-2025
- BLDEW 03-13-2025
- Dividend Yield
- IMAX N/A
- BLDEW N/A
- EPS Growth
- IMAX N/A
- BLDEW N/A
- EPS
- IMAX 0.46
- BLDEW N/A
- Revenue
- IMAX $359,752,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- IMAX $17.23
- BLDEW N/A
- Revenue Next Year
- IMAX $5.25
- BLDEW N/A
- P/E Ratio
- IMAX $60.44
- BLDEW N/A
- Revenue Growth
- IMAX N/A
- BLDEW 12.04
- 52 Week Low
- IMAX $16.33
- BLDEW $0.30
- 52 Week High
- IMAX $29.66
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- IMAX 47.53
- BLDEW N/A
- Support Level
- IMAX $27.00
- BLDEW N/A
- Resistance Level
- IMAX $28.11
- BLDEW N/A
- Average True Range (ATR)
- IMAX 0.85
- BLDEW 0.00
- MACD
- IMAX -0.20
- BLDEW 0.00
- Stochastic Oscillator
- IMAX 20.34
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.